Suchergebnisse - "Lim, Chay Ngee"

PubPharm (30)

11

Dosage regimen for TFPI antagonists

enthalten in: Europäisches Patentamt | 2021

von ZHU TONG | ARKIN STEVEN | CARDINAL MATTHEW H | +2

12

A Phase 1 first‐in‐human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF‐06730512 in healthy participants

enthalten in: Pharmacology Research & Perspectives | 2021

von Lim, C. | Kantaridis, C. | Huyghe, I. | +3

13

DOSAGE REGIMEN FOR TFPI ANTAGONISTS

enthalten in: Europäisches Patentamt | 2020

von ZHU TONG | ARKIN STEVEN | CARDINAL MATTHEW H | +2

14

DOSAGE REGIMEN FOR TFPI ANTAGONISTS

enthalten in: Europäisches Patentamt | 2020

von ZHU TONG | ARKIN STEVEN | CARDINAL MATTHEW H | +2

15

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes : 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249

enthalten in: Diabetes care | 2017

von Kazda, C. | Ding, Y. | Kelly, R. | +10

ErratumFor: Diabetes Care. 2016 Jul;39(7):1241-9. - PMID 26681715

16

Phxnlme : An R package that facilitates pharmacometric workflow of Phoenix NLME analyses

enthalten in: Computer methods and programs in biomedicine | 2017

von Lim, C. | Liang, S. | Feng, K. | +4

17

Phxnlme: An R package that facilitates pharmacometric workflow of Phoenix NLME analyses

enthalten in: Computer methods and programs in biomedicine | 2017

von Lim, C. | Liang, S. | Feng, K. | +4

18

Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes : 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249

enthalten in: Diabetes care | 2016

von Kazda, C. | Ding, Y. | Kelly, R. | +10

CommentOn: Diabetes Care. 2016 Jul;39(7):1241-9. - PMID 26681715

19

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes : 12- and 24-Week Phase 2 Studies

enthalten in: Diabetes care | 2016

von Kazda, C. | Ding, Y. | Kelly, R. | +10

CommentIn: Diabetes Care. 2016 Jul;39(7):1075-7. - PMID 27330122

20

Pharmacokinetic-Pharmacodynamic Modeling of Intravenous and Oral Topiramate and Its Effect on the Symbol-Digit Modalities Test in Adult Healthy Volunteers

enthalten in: Journal of clinical pharmacology | 2016

von Lim, C. | Birnbaum, A. | Brundage, R. | +4